In partnership with the California-based Keck Graduate Institute, Biocon Academy - the educational arm of the pharma company - will launch the Biocon KGI Certificate Programme in Biosciences next year on January 9 in Claremont, California, a press statement said.
"Biocon Academy aims to bring world-class training programmes for biotech students in India through customised programmes like the Biocon KGI Certificate programme in Biosciences and make them employable," Biocon chairperson and managing director, Kiran Mazumdar-Shaw said.
India's Biotech industry is valued at about USD 11 billion, having grown at a compound annual growth rate (CAGR) of more than 20 per cent over the last 10 years.
At present, more than 40,000 biotech students graduate every year from more than 725 institutions across India.
However, lack of hands-on trainings and practical industry exposure prevents many of these students from building a successful career in biotechnology, Shaw said.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
